✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Aarti Drugs Ltd.

AARTIDRUGS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹4,699 Cr.
P/E
24.89

Aarti Drugs Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
4,699 Cr
PE
PE
24.89
Prom Holding
Prom Holding
55.22 %
ROE (%)
ROE (%)
12.28
ROCE (%)
ROCE (%)
14.43
Div Yield (%)
Div Yield (%)
0.19
Sales
Sales
2,422 Cr
OPM (%)
OPM (%)
12.23 %
Debt to Equity
Debt to Equity
0.45
View more
Edit Ratio's

About

Aarti Drugs Limited, established in 1984, is part of Aarti Group of Industries with a strong R… Read more
Low
312
52W Range
High
564
  • Aarti Drugs
  • Supriya Lifescience
  • Solara Active Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

    locked
    Select a Metric
    • APIs Production Capacity (MTPA)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Nizoral

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Customers

    • Abbott India Ltd.
    • Alembic Pharmaceuticals Ltd.
    • Cipla Ltd.
    • Indoco Remedies Ltd.
    • Kopran Ltd.

    FAQs on Aarti Drugs Ltd. Business

    Aarti Drugs Limited, a key player in the pharmaceutical industry, specializes in manufacturing APIs, Pharma Intermediates, Specialty Chemicals, and Formulations including Ciprofloxacin Hydrochloride and Metronidazole.

    Aarti Drugs major competitors are Supriya Lifescience, Solara Active Pharma, IOL Chem & Pharma, SMS Pharmaceuticals, Morepen Laboratories, Shilpa Medicare, Aarti Pharmalabs.
    Market Cap of Aarti Drugs is ₹4,699 Crs.
    While the median market cap of its peers are ₹2,850 Crs.

    Aarti Drugs seems to be less financially stable compared to its competitors.
    Altman Z score of Aarti Drugs is 4.48 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Aarti Drugs Ltd.
    View the discussion on ValuePickr
    AARTI DRUGS vs AARTI PHARMALABS | Which is Best? - Value Educator
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material